← Eichor
Study identifier: NCT07692269 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Mindfulness Intervention for Emotional Distress: An EEG Study

Condition: Emotional Distress · Anxiety · Depression  ·  Sponsor: Peking University

PhaseNA
Planned participants160
Who can joinAll sexes, 18 Years to 50 Years
Healthy volunteersNo

About this study

This is a randomized controlled trial examining the efficacy and neural mechanisms of a standardized Mindfulness Intervention for Emotional Distress (MIED) in adults with subclinical emotional distress. One hundred and sixty participants will be randomly assigned to either an 8-week MIED program or an 8-week Progressive Muscle Relaxation (PMR) active control. The primary aim is to evaluate whether MIED reduces anxiety symptoms and reshapes multilevel emotional processing as measured by multimodal EEG (resting-state FAA/theta, Fast Periodic Visual Stimulation, and event-related potentials). Assessments occur at baseline (T1), post-intervention (T2), and 1-month follow-up.

This description comes directly from the study's public registry record.

Talk to the study team

Qinsi Zheng  ·  +86 13457651658  ·  qszheng25@stu.pku.edu.cn

Xinghua Liu  ·  +86 13371669818  ·  xinghua_liu@pku.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Peking University, School of Psychological and Cognitive SciencesBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07692269